Start your Trading & Investing Journey with us

Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates

NEPHRO CARE INDIA IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

NEPHRO CARE INDIA Limited Financial Information (Restated Consolidated)

Amount in (₹ in Lakhs)

Period Ended Dec 31, 2023 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Reserve of Surplus 1,332.81 193.76 -0.48 0.50
Total Assets 2,029.85 831.11 462.93 112.84
Total Borrowings - 246.39 253.74 69.27
Fixed Assets 259.15 304.96 139.36 5.80
Cash 215.69 231.66 60.90 48.22
Cash flow from operating activities
Cash flows from investing activities
Cash flow from financing activities
Net Borrowing -215.69 14.73 192.84 21.05
Revenue 1,989.60 1,709.51 342.70 183.26
EBITDA 25.55 21.33 3.67 8.47
PAT 340.04 194.24 -0.98 8.87
PAT Margin
EPS 3.36 1.94 -0.03 4.44

Note 1:- ROCE & ROE calculation in KPI is based on 31st Dec, 2023 Data, given in RHP.
Note 2:- Pre EPS and Post EPS in KPI is based on 31st Mar, 2023 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Dec, 2023 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after completion of Offer Price.
Note 5:- There are no listed companies for peer comparison. 

© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com